Lower NPY levels were observed in pheochromocytomas from von Hippel-Lindau patients (noradrenergic phenotype) when compared with pheochromocytomas from multiple endocrine neoplasia type 2 patients (adrenergic phenotype) [225]. Here, NPY is linked to pheochromocytoma.